• Crossbow Therapeutics Raises $77M in Series B Funding
Taiho Ventures - Latest News and Investment Deals
  • All Technology
  • AI
  • Autonomy
  • B2B Growth
  • Big Data
  • BioTech
  • ClimateTech
  • Consumer Tech
  • Cybersecurity
  • DevOps
  • Digital Marketing
  • Ecommerce
  • EdTech
  • Enterprise
  • FinTech
  • GovTech
  • Hardware
  • HealthTech
  • HRTech
  • LegalTech
  • Nanotech
  • PropTech
  • Quantum
  • Robotics
  • SaaS
  • SpaceTech
AllNewsDealsSocialBlogsVideosPodcastsDigests

Technology Pulse

EMAIL DIGESTS

Daily

Every morning

Weekly

Tuesday recap

Top Publishers

Top Creators

  • Ryan Allis

    Ryan Allis

    194 followers

  • Elon Musk

    Elon Musk

    78 followers

  • Sam Altman

    Sam Altman

    68 followers

  • Mark Cuban

    Mark Cuban

    56 followers

  • Jack Dorsey

    Jack Dorsey

    39 followers

See More →

Top Companies

  • SaasRise

    SaasRise

    196 followers

  • Anthropic

    Anthropic

    39 followers

  • OpenAI

    OpenAI

    21 followers

  • Hugging Face

    Hugging Face

    15 followers

  • xAI

    xAI

    12 followers

See More →

Top Investors

  • Andreessen Horowitz

    Andreessen Horowitz

    16 followers

  • Y Combinator

    Y Combinator

    15 followers

  • Sequoia Capital

    Sequoia Capital

    12 followers

  • General Catalyst

    General Catalyst

    8 followers

  • A16Z Crypto

    A16Z Crypto

    5 followers

See More →
NewsDealsSocialBlogsVideosPodcasts
HomeTaiho Ventures
Taiho Ventures logo

Taiho Ventures

0 followers

About Taiho Ventures

Taiho Ventures, LLC is an investment firm focused on funding global biotech ventures in alignment with Taiho Pharmaceutical Co., Ltd.’s growth strategy. The company aims to create significant value by supporting innovative science within the biotechnology and pharmaceutical ecosystem and fostering collaborations with Taiho’s corporate network. It emphasizes investments that advance therapeutics and drug development through partnerships and strategic affiliations. Based in the United States, Taiho Ventures coordinates with international biotech startups and companies seeking to accelerate translational science and clinical value for Taiho Oncology and related ventures.

Recent News

No recent news for this company.

Recent Deals

Crossbow Therapeutics Raises $77M in Series B Funding

March 18, 2026

Key Team Members

Sakae Asanuma

President & CEO

Seiji Miyahara

Partner & Senior Investment Director

Key Facts

HQ Location

Menlo Park, United States

Founded

2016

Employees

1 - 10

Status

Investor

Investor Type

Corporate Investor

Website

https://taihoventures.com